Abstract
Cardiac resynchronization therapy (CRT) is relatively new treatment for symptoms associated with congestive heart failure (HF) which is achieved by simultaneously pacing both the left and right ventricles of the heart. Current clinical guidelines support the use of CRT in moderate or severe HF patients with a left ventricular (LV) ejection fraction of ≤35% and a prolonged QRS interval (≥120 ms), characteristic of electrical dyssynchrony. Several clinical studies have reported high non-response rates to CRT and have questioned the accuracy of currently practiced patient-selection criteria for this therapy. In this study we demonstrate the translational application of medical imaging biomarkers of phase of ventricular contraction quantified from cardiac magnetic resonance (CMR) imaging, in defining correlations between mechanical dysynchrony (MD) and electrical dyssynchrony, in an effort to identify a means to relate the best-practices for positioning an LV pacing lead (viz. localized to the latest mechanically activating, non-scarred regions) with the clinical guidelines for electrical dyssynchrony in a cohort of heart failure (HF). We retrospectively examine two cohorts of HF patients with different electrical conduction characteristics: a) Left bundle branch block (LBBB) and wide QRS interval – defining the Class I indication for CRT – characteristic of electrical dyssynchrony as evidenced from electrocardiograms; and b) HF with large antero-apical aneurysms and scarring but narrow QRS interval. Indices of mean and standard deviation in phase of regional contraction were examined across the entire LV of each patient, including scarred territories. Additionally, contraction timing delay between the septal and lateral cardiac walls were also examined in the basal LV territories which were free from adverse remodelling and scar. The results from this pilot study show that MD assessment using CMR imaging based biomarkers of phase of LV contraction is highly accurate in predicting electrical dyssynchrony defined by QRS duration ≥150 ms, with receiver operator characteristics evidencing close to perfect accuracy when MD was analyzed in LV territories which excluded scar.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abraham, W.T., Fisher, W.G., Smith, A.L., et al.: Cardiac resynchronization in chronic heart failure. N. Engl. J. Med. 346(24), 1845–1853 (1845)
Cazeau, S., Leclercq, C., Lavergne, T., et al.: Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N. Engl. J. Med. 344(12), 873–880 (2001)
Strickberger, S.A., Conti, J., Daoud, E.G., et al.: Patient selection for cardiac resynchronization therapy: from the Council on Clinical Cardiology Subcommittee on Electrocardiography and Arrhythmias and the Quality of Care and Outcomes Research Interdisciplinary Working Group, in collaboration with the Heart Rhythm Society. Circulation 111, 2146–2150 (2005)
Beshai, J.F., Grimm, R.A., Nagueh, S.F., et al.: Cardiac-resynchronization therapy in heart failure with narrow QRS complexes. N. Engl. J. Med. 357(24), 2461–2471 (2007)
Bax, J.J., Gorcsan, J.: 3rd, Echocardiography and noninvasive imaging in cardiac resynchronization therapy: results of the PROSPECT (Predictors of Response to Cardiac Resynchronization Therapy) study in perspective. J. Am. Coll. Cardiol. 53(21), 1933–1943 (2009)
Young, J.B., Abraham, W.T., Smith, A.L., et al.: Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. Jama 289(20), 2685–2694 (2003)
Leclercq, C., Kass, D.A.: Retiming the failing heart: principles and current clinical status of cardiac resynchronization. J. Am. Coll. Cardiol. 39(2), 194–201 (2002)
Chung, E.S., Leon, A.R., Tavazzi, L., et al.: Results of the Predictors of Response to CRT (PROSPECT) trial. Circulation, 2008 117(20), 2608–2616 (2008)
Boogers, M.J., Chen, J., van Bommel, R.J., et al.: Optimal left ventricular lead position assessed with phase analysis on gated myocardial perfusion SPECT. Eur. J. Nucl. Med. Mol Imaging 38(2), 230–238 (2011)
Delgado, V., van Bommel, R.J., Bertini, M., et al.: Relative merits of left ventricular dyssynchrony, left ventricular lead position, and myocardial scar to predict long-term survival of ischemic heart failure patients undergoing cardiac resynchronization therapy. Circulation 123(1), 70–78 (2011)
Ypenburg, C., van Bommel, R.J., Delgado, V., et al.: Optimal Left Ventricular Lead Position Predicts Reverse Remodeling and Survival After Cardiac Resynchronization Therapy. J. Am. Coll. Cardiol. 52(17), 1402–1409 (2008)
Khan, F.Z., Virdee, M.S., Palmer, C.R., et al.: Targeted Left Ventricular Lead Placement to Guide Cardiac Resynchronization Therapy: The TARGET Study: A Randomized, Controlled Trial. J. Am. Coll. Cardiol. 12, j.jacc.2011.12.030 (2011)
Heiberg, E., Sjogren, J., Ugander, M., et al.: Design and validation of Segment–freely available software for cardiovascular image analysis. BMC Med. Imaging 10(1), 1 (2010)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer International Publishing Switzerland
About this paper
Cite this paper
Menon, P.G., Adhyapak, S.M., Parachuri, V.R. (2014). Analysis of Cardiac MRI Based Regional Timing of Left Ventricular Mechanical Contraction as a Biomarker for Electrical Dyssynchrony in Heart-Failure Patients. In: Zhang, Y.J., Tavares, J.M.R.S. (eds) Computational Modeling of Objects Presented in Images. Fundamentals, Methods, and Applications. CompIMAGE 2014. Lecture Notes in Computer Science, vol 8641. Springer, Cham. https://doi.org/10.1007/978-3-319-09994-1_5
Download citation
DOI: https://doi.org/10.1007/978-3-319-09994-1_5
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-09993-4
Online ISBN: 978-3-319-09994-1
eBook Packages: Computer ScienceComputer Science (R0)